Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases.

The multifunctional molecule netrin-1 is upregulated in various malignancies and has recently been presented as a major general player in tumorigenesis leading to tumor progression and maintenance in various animal models. However, there is still a lack of clinico-epidemiological data related to net...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Patrick N Harter, Jenny Zinke, Alexander Scholz, Julia Tichy, Cornelia Zachskorn, Hans M Kvasnicka, Benjamin Goeppert, Céline Delloye-Bourgeois, Elke Hattingen, Christian Senft, Joachim P Steinbach, Karl H Plate, Patrick Mehlen, Dorothea Schulte, Michel Mittelbronn
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/02239f747ee44b2a98086e30e7b0add9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:02239f747ee44b2a98086e30e7b0add9
record_format dspace
spelling oai:doaj.org-article:02239f747ee44b2a98086e30e7b0add92021-11-18T08:27:17ZNetrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases.1932-620310.1371/journal.pone.0092311https://doaj.org/article/02239f747ee44b2a98086e30e7b0add92014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24647424/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203The multifunctional molecule netrin-1 is upregulated in various malignancies and has recently been presented as a major general player in tumorigenesis leading to tumor progression and maintenance in various animal models. However, there is still a lack of clinico-epidemiological data related to netrin-1 expression. Therefore, the aim of our study was to elucidate the association of netrin-1 expression and patient survival in brain metastases since those constitute one of the most limiting factors for patient prognosis. We investigated 104 brain metastases cases for netrin-1 expression using in-situ hybridization and immunohistochemistry with regard to clinical parameters such as patient survival and MRI data. Our data show that netrin-1 is strongly upregulated in most cancer subtypes. Univariate analyses revealed netrin-1 expression as a significant factor associated with poor patient survival in the total cohort of brain metastasis patients and in sub-entities such as non-small cell lung carcinomas. Interestingly, many cancer samples showed a strong nuclear netrin-1 signal which was recently linked to a truncated netrin-1 variant that enhances tumor growth. Nuclear netrin-1 expression was associated with poor patient survival in univariate as well as in multivariate analyses. Our data indicate both total and nuclear netrin-1 expression as prognostic factors in brain metastases patients in contrast to other prognostic markers in oncology such as patient age, number of brain metastases or Ki67 proliferation index. Therefore, nuclear netrin-1 expression constitutes one of the first reported molecular biomarkers for patient survival in brain metastases. Furthermore, netrin-1 may constitute a promising target for future anti-cancer treatment approaches in brain metastases.Patrick N HarterJenny ZinkeAlexander ScholzJulia TichyCornelia ZachskornHans M KvasnickaBenjamin GoeppertCéline Delloye-BourgeoisElke HattingenChristian SenftJoachim P SteinbachKarl H PlatePatrick MehlenDorothea SchulteMichel MittelbronnPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 3, p e92311 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Patrick N Harter
Jenny Zinke
Alexander Scholz
Julia Tichy
Cornelia Zachskorn
Hans M Kvasnicka
Benjamin Goeppert
Céline Delloye-Bourgeois
Elke Hattingen
Christian Senft
Joachim P Steinbach
Karl H Plate
Patrick Mehlen
Dorothea Schulte
Michel Mittelbronn
Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases.
description The multifunctional molecule netrin-1 is upregulated in various malignancies and has recently been presented as a major general player in tumorigenesis leading to tumor progression and maintenance in various animal models. However, there is still a lack of clinico-epidemiological data related to netrin-1 expression. Therefore, the aim of our study was to elucidate the association of netrin-1 expression and patient survival in brain metastases since those constitute one of the most limiting factors for patient prognosis. We investigated 104 brain metastases cases for netrin-1 expression using in-situ hybridization and immunohistochemistry with regard to clinical parameters such as patient survival and MRI data. Our data show that netrin-1 is strongly upregulated in most cancer subtypes. Univariate analyses revealed netrin-1 expression as a significant factor associated with poor patient survival in the total cohort of brain metastasis patients and in sub-entities such as non-small cell lung carcinomas. Interestingly, many cancer samples showed a strong nuclear netrin-1 signal which was recently linked to a truncated netrin-1 variant that enhances tumor growth. Nuclear netrin-1 expression was associated with poor patient survival in univariate as well as in multivariate analyses. Our data indicate both total and nuclear netrin-1 expression as prognostic factors in brain metastases patients in contrast to other prognostic markers in oncology such as patient age, number of brain metastases or Ki67 proliferation index. Therefore, nuclear netrin-1 expression constitutes one of the first reported molecular biomarkers for patient survival in brain metastases. Furthermore, netrin-1 may constitute a promising target for future anti-cancer treatment approaches in brain metastases.
format article
author Patrick N Harter
Jenny Zinke
Alexander Scholz
Julia Tichy
Cornelia Zachskorn
Hans M Kvasnicka
Benjamin Goeppert
Céline Delloye-Bourgeois
Elke Hattingen
Christian Senft
Joachim P Steinbach
Karl H Plate
Patrick Mehlen
Dorothea Schulte
Michel Mittelbronn
author_facet Patrick N Harter
Jenny Zinke
Alexander Scholz
Julia Tichy
Cornelia Zachskorn
Hans M Kvasnicka
Benjamin Goeppert
Céline Delloye-Bourgeois
Elke Hattingen
Christian Senft
Joachim P Steinbach
Karl H Plate
Patrick Mehlen
Dorothea Schulte
Michel Mittelbronn
author_sort Patrick N Harter
title Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases.
title_short Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases.
title_full Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases.
title_fullStr Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases.
title_full_unstemmed Netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases.
title_sort netrin-1 expression is an independent prognostic factor for poor patient survival in brain metastases.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/02239f747ee44b2a98086e30e7b0add9
work_keys_str_mv AT patricknharter netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT jennyzinke netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT alexanderscholz netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT juliatichy netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT corneliazachskorn netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT hansmkvasnicka netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT benjamingoeppert netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT celinedelloyebourgeois netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT elkehattingen netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT christiansenft netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT joachimpsteinbach netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT karlhplate netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT patrickmehlen netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT dorotheaschulte netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
AT michelmittelbronn netrin1expressionisanindependentprognosticfactorforpoorpatientsurvivalinbrainmetastases
_version_ 1718421721559597056